IRIS
BELTRAMI, MATTEO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.092
AS - Asia 1.811
EU - Europa 1.659
SA - Sud America 494
AF - Africa 42
OC - Oceania 3
Totale 7.101
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.027
RU - Federazione Russa 734
CN - Cina 553
SG - Singapore 539
BR - Brasile 414
HK - Hong Kong 219
IT - Italia 200
GB - Regno Unito 190
VN - Vietnam 182
IE - Irlanda 128
KR - Corea 128
DE - Germania 88
SE - Svezia 75
UA - Ucraina 69
IN - India 63
FR - Francia 55
FI - Finlandia 51
MX - Messico 33
AR - Argentina 30
BD - Bangladesh 24
IQ - Iraq 17
CA - Canada 15
PL - Polonia 15
ID - Indonesia 13
JP - Giappone 13
NL - Olanda 13
TR - Turchia 12
EC - Ecuador 11
PY - Paraguay 10
ZA - Sudafrica 10
BE - Belgio 8
CO - Colombia 8
IR - Iran 8
KE - Kenya 8
SA - Arabia Saudita 8
CL - Cile 7
VE - Venezuela 7
PE - Perù 6
CI - Costa d'Avorio 5
LT - Lituania 5
MA - Marocco 5
CZ - Repubblica Ceca 4
EG - Egitto 4
ES - Italia 4
KZ - Kazakistan 4
TN - Tunisia 4
TT - Trinidad e Tobago 4
AT - Austria 3
BB - Barbados 3
JM - Giamaica 3
PH - Filippine 3
PK - Pakistan 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
BH - Bahrain 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
ET - Etiopia 2
GR - Grecia 2
GT - Guatemala 2
IL - Israele 2
JO - Giordania 2
KG - Kirghizistan 2
MY - Malesia 2
PT - Portogallo 2
RS - Serbia 2
AZ - Azerbaigian 1
BG - Bulgaria 1
BO - Bolivia 1
BW - Botswana 1
CH - Svizzera 1
CR - Costa Rica 1
HN - Honduras 1
HU - Ungheria 1
IM - Isola di Man 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
NG - Nigeria 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PS - Palestinian Territory 1
RO - Romania 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
Totale 7.101
Salva come PNG Salva come JPEG
Città #
Dallas 1.538
Singapore 324
Moscow 246
Hong Kong 218
Hefei 158
Fairfield 151
Ashburn 147
Beijing 140
Southend 136
Seoul 128
Dublin 127
Ann Arbor 76
Woodbridge 71
Seattle 68
Chandler 66
Houston 66
Santa Clara 64
Ho Chi Minh City 62
Los Angeles 59
Jacksonville 54
Wilmington 54
Cambridge 43
Munich 40
Hanoi 35
Bengaluru 34
Milan 32
São Paulo 29
Dong Ket 27
The Dalles 27
San Nicola la Strada 26
Buffalo 25
New York 24
Siena 24
Turku 24
Princeton 23
Düsseldorf 21
Lauterbourg 20
Redondo Beach 19
Mexico City 18
Rome 18
Denver 17
Nanjing 17
Chicago 15
Warsaw 15
Portsmouth 14
Rio de Janeiro 14
Florence 13
San Giuliano Terme 13
Brasília 12
Dearborn 12
Tokyo 12
Brooklyn 11
Boardman 10
Helsinki 9
Phoenix 9
Shanghai 9
Baghdad 8
Brussels 8
Columbus 8
Haiphong 8
Tehran 8
Bologna 7
Boston 7
Chennai 7
Lancaster 7
Lappeenranta 7
Porto Alegre 7
San Mateo 7
Atlanta 6
Belo Horizonte 6
Council Bluffs 6
Frankfurt am Main 6
Goiânia 6
Guangzhou 6
Hebei 6
Montreal 6
Nairobi 6
Tianjin 6
Abidjan 5
Biên Hòa 5
Curitiba 5
Dhaka 5
Guayaquil 5
Jiaxing 5
Johannesburg 5
Nanchang 5
New Delhi 5
Shenyang 5
Toronto 5
Asunción 4
Bari 4
Basra 4
Belford Roxo 4
Blumenau 4
Cagliari 4
Changsha 4
Da Nang 4
Falls Church 4
Guarulhos 4
Indaiatuba 4
Totale 4.912
Salva come PNG Salva come JPEG
Nome #
The Treatment of Heart Failure in Patients with Chronic Kidney Disease: Doubts and New Developments from the Last ESC Guidelines 404
Admission plasma neutrophil gelatinase associated lipocalin (NGAL) predicts worsening renal function during hospitalization and post discharge outcome in patients with acute heart failure. 249
Prognostic significance of hyperuricemia in patients with acute heart failure 242
Different trajectories and significance of B-type natriuretic peptide, congestion and acute kidney injury in patients with heart failure 238
Coronary microvascular function is impaired in patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) 212
Patients with cardiorenal syndrome revealed increased neurohormonal activity, tubular and myocardial damage compared to heart failure patients with preserved renal function 211
The role of fibrosis and inflammation for response and outcome prediction in candidates to cardiac resynchronization therapy: is response the right answer? 207
Loop Diuretics Strategies in Acute Heart Failure: From Clinical Trials to Practical Application 207
Neuthrophil gelatinase associated lipocalin better predicts early acute kidney injury and outcome respect to bnp and cystatin c in acute heart failure patients 205
Variation in Bone Turnover Markers in Professional Sport Players During Training is Mediated by Changes in Sclerostin Levels 202
Incidence of stroke in patients with hypertrophic cardiomyopathy implanted with a cardiac implantable electronic device 200
The role of natriuretic peptides for the diagnosis of left ventricular dysfunction 191
Natriuretic peptides and NGAL in heart failure: does a link exist? 189
Diagnostic utility of contemporary echo and BNP assessment in patients with acute heart failure during early hospitalization 187
Current therapeutic strategies in cardiorenal syndrome 179
The impact of infarct size on regional and global left ventricular systolic function: a cardiac magnetic resonance imaging study 174
The potential role of natriuretic peptides in acute coronary syndrome stratification 158
From gene mutations to biomechanical abnormalities and electrophysiological remodeling in hypertrophic cardiomyopathy: exploring the translational approach. 141
Additional value of Galectin-3 to BNP in acute heart failure patients with preserved ejection fraction 128
Paradoxical prolongation of QT interval during exercise in patients with hypertrophic cardiomyopathy: cellular mechanisms and implications for diastolic function 105
Are HFpEF and HFmrEF So Different? The Need to Understand Distinct Phenotypes 100
Clinical, Laboratory and Lung Ultrasound Assessment of Congestion in Patients with Acute Heart Failure 100
Cardiac resynchronization therapy improves functional status and cognition 94
Combined use of lung ultrasound, B-type natriuretic peptide, and echocardiography for outcome prediction in patients with acute HFrEF and HFpEF 94
Additional value of Galectin-3 respect to BNP in acute heart failure patients with preserved ejection fraction 89
Acute COVID-19 Management in Heart Failure Patients: A Specific Setting Requiring Detailed Inpatient and Outpatient Hospital Care 81
Beyond Natriuretic Peptides: Unveiling the Power of Emerging Biomarkers in Heart Failure 79
Cardio-renal syndrome revealed increased neurohormonal activity, tubular and myocardial damage respect to heart failure patients with preserved renal function 77
Clinical impact of renal dysfunction in heart failure 76
The role of fibrosis, inflammation, and congestion biomarkers for outcome prediction in candidates to cardiac resynchronization therapy: is “response” the right answer? 76
Comparison of Demographic, Clinical, Biochemical, and Imaging Findings in Hypertrophic Cardiomyopathy Prognosis: A Network Meta-Analysis 73
The predictive value of plasma biomarkers in discharged heart failure patients: the role of plasma BNP 71
Chronotropic incompetence across heart failure categories 68
Frailty, sarcopenia and cachexia in heart failure patients: Different clinical entities of the same painting 68
Cardiac involvement in eosinophilic granulomatosis with polyangiitis (formerly Churg-Strauss syndrome): Prospective evaluation at a tertiary referral centre 65
Relationship between measures of left ventricular systolic and diastolic dysfunction and clinical and biomarker status in patients with hypertrophic cardiomyopathy 63
Long-Term Prevalence of Systolic Dysfunction in MYBPC3 Versus MYH7-Related Hypertrophic Cardiomyopathy 62
The Role of the Left Atrium: From Multimodality Imaging to Clinical Practice: A Review 61
Laboratory and Metabolomic Fingerprint in Heart Failure with Preserved Ejection Fraction: From Clinical Classification to Biomarker Signature 60
The relevance of specific heart failure outpatient programs in the COVID era: An appropriate model for every disease 59
Relation of QRS duration to response to cardiac resynchronization therapy 59
Incidence of stroke in patients with hypertrophic cardiomyopathy in stable sinus rhythm during long-term monitoring 58
Multimodality Imaging in Sarcomeric Hypertrophic Cardiomyopathy: Get It Right…on Time 58
Pathophysiological Link and Treatment Implication of Heart Failure and Preserved Ejection Fraction in Patients with Chronic Kidney Disease 57
Continuous versus intermittent loop diuretics infusion dosing in acute heart failure: effects on renal function, outcome and BNP levels 57
Integrated Cardiorespiratory Rehabilitation and Its Impact on Cardio-Renal-Metabolic Profile After Cardiac Surgery 57
Exercise-induced pulmonary hypertension in hypertrophic cardiomyopathy: a combined cardiopulmonary exercise test—echocardiographic study 56
Coronary microvascular function is impaired in patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy 55
The Different Pathways of Epicardial Adipose Tissue across the Heart Failure Phenotypes: From Pathophysiology to Therapeutic Target 53
Patient phenotype profiling using echocardiography and natriuretic peptides to personalise heart failure therapy 53
Circulating Biomarkers in Pulmonary Arterial Hypertension: An Update 52
Relation of QRS Duration to Response to Cardiac Resynchronization Therapy in Patients With Left Bundle Branch Block 52
Contemporary assessment of lung ultrasound, BNP and echocardiography for outcome prediction in patients with decompensated heart failure 51
Different neurohormonal and inflammatory pattern in acute CRS respect to AHF patients with preserved renal function 51
Prevalence, causes and predictors of cardiovascular hospitalization in patients with hypertrophic cardiomyopathy 49
COMPARISON OF DEMOGRAPHIC, CLINICAL, BIOCHEMICAL AND IMAGING AND IMAGING FINDINGS IN HYPERTROPHIC CARDIOMYOPATHY PROGNOSIS: A NETWORK META-ANALYSES 46
ATRIOVENTRICULAR BLOCK, AN UNUSUAL CLINICAL PRESENTATION OF CALCIFIED BICUSPID AORTIC VALVE 46
Contemporary assessment of lung ultrasound, bnp and echocardiography predicts outcome in patients with acute heart failure independently to systolic dysfunction 46
Short and long-term effects of continuous versus intermittent loop diuretics treatment in acute heart failure with renal dysfunction 45
Cardiac involvement in Churg Strauss syndrome: an update on cardiological manifestations 44
Cost-effectiveness and diagnostic accuracy of focused cardiac ultrasound in the pre-participation screening of athletes: the SPORT-FoCUS study 44
Heart failure with preserved ejection fraction in elderly. From pathophysiology to treatment: An unresolved problem 43
The assessment, interpretation and implementation of lung ultrasound examinations in Heart Failure: Current evidence and gaps in knowledge 42
Longitudinal function and right ventricular remodeling ratio in acute heart failure: a non invasive measurement of right dysfunction and outcome 41
Comparison of long-term clinical course and outcome of MYBPC3-versus MYH7-related hypertrophic cardiomyopathy 40
The Role of Multimodality Imaging in Pediatric Cardiomyopathies 39
The importance of integrated left atrial evaluation: From hypertension to heart failure with preserved ejection fraction 37
Systematic large-scale assessment of the genetic architecture of left ventricular noncompaction reveals diverse etiologies 36
Combination Between Biomarkers and Echocardiographic Data for Prediction of Left Ventricular Reverse Remodelling in Cardiac Resynchronization Therapy 35
Early administration of SGLT2 inhibitors in hospitalized patients: A practical guidance from the current evidence 31
Multi-biomarkers laboratory strategy for outcome prediction in patients with severe systolic dysfunction submitted to CRT 31
The Role of Lung Ultrasound Scan in Different Heart Failure Scenarios: Current Applications and Lacks of Evidences 31
Usefulness of contemporary echo and bnp assessment during early hospitalization in patients with acute heart failure 29
Paradoxical prolongation of QT interval during exercise in patients with hypertrophic cardiomyopathy 26
Transient versus persistent worsening renal function during hospitalization in acute heart failure: different phenotypes for different outcome 24
Cardiac resynchronization therapy improves functional status and cognition at long term follow-up 23
Plasma Neuthrophil Gelatinase associated Lipocalin (NGAL) predict worsening renal function and outcome in patients with acute decompensated heart failure 22
The genetic architecture of left ventricular non-compaction reveals both substantial overlap with other cardiomyopathies and a distinct aetiology in a subset of cases 22
Functional capacity and neurocognitive profile: the effects of cardiac resynchronization therapy 20
Myocarditis and Chronic Inflammatory Cardiomyopathy, from Acute Inflammation to Chronic Inflammatory Damage: An Update on Pathophysiology and Diagnosis 18
Prognostic significance of asymptomatic hyperuricemia and allopurinol therapy in chronic systolic HF outpatients 14
Eosinophilic granulomatosis with polyangiitis, a new recurrent feature in an extremely rare disease 14
Ventricular arterial coupling alteration and long term prognosis in patients with hypertrophic cardiomyopathy 12
Prognostic Value of Malnutrition, Frailty, and Physical Performance in Transthyretin Cardiac Amyloidosis: Insights From a Prospective Multicenter Cohort Study 12
Exercise induced pulmonary hypertension in hypertrophic cardiomyopathy: a combined cardiopulmonary exercise test-echocardiographic study 10
Prevalence of device-detected atrial fibrillation and stroke in patients with hypertrophic cardiomyopathy 10
PLN-related obstructive hypertrophic cardiomyopathy responsive to mavacamten 9
The impact of surgical myectomy on exercise capacity among patients with obstructive hypertrophic cardiomyopathy: Insights from Echo-CPET analysis 7
Incidental cardiac mass: Differential diagnosis, clinical approach and review of the literature,Massa cardiaca incidentale: Diagnosi differenziale, approccio clinico e revisione della letteratura 7
Left bundle branch area pacing with stylet driven lead in third-degree atrioventricular block following Morrow surgery 6
Heart failure and chronic obstructive pulmonary disease. A combination not to be underestimated 5
Totale 7.330
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.470
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.470
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021196 0 0 0 0 0 30 24 34 9 39 24 36
2021/2022162 11 16 9 21 11 9 7 8 6 20 16 28
2022/2023266 16 18 36 30 30 48 6 20 20 6 7 29
2023/2024189 7 4 25 3 4 51 66 7 2 2 1 17
2024/20251.546 11 12 22 15 52 131 159 88 115 116 197 628
2025/20264.139 461 812 1.290 681 871 24 0 0 0 0 0 0
Totale 7.330